Login
Specialities

Specialities

Arrhythmia
Atherosclerosis
Atrial Fibrillation
Cardiovascular Disease
Congenital Conditions
COVID-19
Electrophysiology
Heart Failure
Hypertension
Imaging
Interventional Cardiology
Obesity
Syncope
Stroke
Thrombosis
Search
Register
Login

Trending Topic
15 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Community-based Participatory Research in Cardiovascular Disease Prevention for Middle-aged Women: A Systematic Review

Rnda I Ashgar

Cardiovascular disease (CVD) continues to be the primary cause of mortality and morbidity globally with middle-aged women presenting with additional and possibly, overlooked risk factors.1 Despite several awareness programmes, there remain several gaps in the political education and representation needs of this group, which includes those from low socioeconomic status (SES) and culturally diverse backgrounds. These […]

Heart International. 2025;19(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin
Arrhythmia Atrial Fibrillation
0:52 mins

Trudie Lobban MBE Global AF Aware Week 2020 – Healthcare Pioneers Report

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 17th 2020
Trudie Lobban MBE  (CEO and Trustee, A-A, AF Association & STARS) shares her highlights from the Global AF Aware Week 2020 – Healthcare Pioneers Report.  For more information visit: https://heartrhythmalliance.org/aa/uk/af-aware-week
Trudie Lobban MBE is CEO and Trustee at A-A, AF Association & STARS and has no financial disclosures in relation to this video.

Commissioned, edited and funded by Touch Medical Media.

Filmed during a remote video call with Trudie Lobban, MBE, FRCP (Edin), Winter 2020.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation

David Conen

The challenges of improving risk prediction in atrial fibrillation were brought to the forefront through recent research on multiple biomarkers. This work explores how various biomarkers are linked to different outcomes and their potential to refine risk prediction. Early findings suggest that no single pathway is responsible for the observed outcomes, underscoring the need for larger, more comprehensive studies. Such studies must include a wide range of biomarkers and phenotypic associations to accurately determine and predict the diverse outcomes in patients with atrial fibrillation.

Advertisement

    • Related Videos in Atrial Fibrillation

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup